Latest filing published 18 Nov 2020 for Revolution Medicines, Inc., €29.3M.
Filing timeline
BuySaleInsider track record
Column Group III, LP: trading record in brief
Column Group III, LP appears in our data through filings on Revolution Medicines, Inc. shares, published by SEC (Form 4). We count 4 filings; the first trade dates from 18 February 2020 and the latest from 16 November 2020.
Sales make up the whole of the open-market record (2 sales, €62.3M).
On 18 November 2020 came the latest disclosure, an open-market sale for €29.3M in Revolution Medicines, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Column Group III, LP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 952,023 shares@ US$36.4047.0% of flowCommon StockSEC:0000899243-20-031483:0
- 1,075,133 shares@ US$36.4053.0% of flowCommon StockSEC:0000899243-20-031483:1
- 7,234 shares0Common StockSEC:0001209191-20-037956:0
- 7,977,384 sharesCommon StockSEC:0001209191-20-010107:0
4 of 4 declarations
